It may also be helpful for those who are on tight blood sugar control, also known as intensive insulin therapy. The Dexcom G6 and G7 devices are approved by the Food and Drug Administration (FDA) for ...

If you're not convinced that 2025 might already belong to LiAngelo, or his rap name, G3, here is a timeline of what has happened since his music career took off. Gelo sets it off at NBA All-Star ...

On Thursday, Dexcom, Inc.'s (NASDAQ:DXCM) fourth-quarter revenue rose 8% year-over-year to $1.114 billion, beating the analyst consensus estimate of $1.104 billion. U.S. revenue rose by 4% ...

Management believes organic revenue is a meaningful metric to investors as it provides a more consistent comparison of Dexcom’s revenue to prior periods as well as to industry peers. We exclude ...

Analyst Price Forecast Suggests 14.60% Upside As of January 28, 2025, the average one-year price target for DexCom is $99.51/share. The forecasts range from a low of $75.75 to a high of $131.25.